• mtc-call-for-sessions_advamed-homepage.jpg

Top News

Press Release | February 5, 2019
The Advanced Medical Technology Association (AdvaMed) today announced that Amanda Walsh has joined the association as its associate vice president for government affairs.
Press Release | January 29, 2019
WASHINGTON, D.C. – A medical technology and health IT task force of medical device manufacturers, trade associations, FDA representatives and other health industry stakeholders – operating as part of the Healthcare Sector Coordinating Council (HSCC) – today unveiled the Medical Device and Health IT Joint Security Plan (JSP) to address challenges the health care industry faces when securing and protecting itself against cybersecurity incidents, both intentional and unintentional.
Press Release | January 24, 2019
Washington, D.C. – The medical technology community is already feeling the effects of the partial government shutdown. Under current law, FDA cannot review new fee-paying medical device applications for market clearance, and, as a result, the innovation pipeline is becoming dangerously clogged. New treatments and cures are stuck in a queue, and patients could see those effects.


April 16, 2019 to April 17, 2019
| Washington, DC
Register by March 8 and save $200 with early bird pricing! How do you implement and measure the effectiveness of a complaint handling system covering a diverse set of possible products and problems?... Read More
April 17, 2019 to April 18, 2019
| Washington, DC
Register by March 8th and save $200 with early bird pricing! During ​this ​workshop ​you'll ​establish ​a ​clear ​understanding ​how ​the ​regulatory ​affairs ​function ​is ​pivotal ​to ​every ​... Read More
April 17, 2019 to April 18, 2019
| Washington, DC
Register by March 8th and save $200 with early bird pricing! AdvaMed’s Annual Payment Policy Conference brings together device manufacturers, hospitals, insurers, CMS, and Capitol Hill for in-depth... Read More
April 23, 2019 | Washington, DC
This workshop is considered "Day 0" to the 12th Annual FDA/AdvaMed Medical Devices and Diagnostics Statistical Issues Conference. Professionals often attend both the workshop and the conference. The... Read More
April 24, 2019 to April 25, 2019
| Washington, DC
This annual conference brings together leading authorities from FDA, industry and academia to address the latest statistical trends and issues facing medtech organizations. This conference allows... Read More

Industry News

Digital Journal
SAN DIEGO, CA - iAssay® Inc., a privately held developer of the world's first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 13/074,209. The allowed patent includes 66 claims relating to multiple types of patient tests, wireless communications, plug-in modules, and user guides. The patent application is expected to issue in mid-2019...
AMSTERDAM, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced Azurion with FlexArm, to set a new standard for patient imaging and positioning flexibility for image-guided procedures.  During increasingly complex interventions, clinicians need to quickly and easily visualize critical anatomy and identify changes to the patient during the procedure. Azurion with FlexArm includes a set of innovations that makes it easier for the clinician...
RTI Surgical®
ALACHUA, Fla., – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction...
Med-Tech Innovation News
The report, from a coalition of stakeholders including leaders from patient groups, academia, government and the private sector, makes several recommendations in an attempt to improve and expand access to advanced radiotherapy services in the UK.
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.

Twitter Feed

February 18, 2019 - 10:02am
Natalie and James made a match on a single blind date. Now, they’re married. This is their story. https://t.co/QKVVnO6cRv
February 15, 2019 - 2:41pm
RT : .⁦⁦⁩’s ⁦⁩ discussing the important role is playing in combatting the… https://t.co/yNqkxySyq7